A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Sudden Sensorineural Hearing Loss after Granulocyte-Colony Stimulating Factor Administration
2018
Journal of Clinical Otolaryngology
Filgrastim Ⓡ (Granulocyte-colony stimulating factor, G-CSF) is generally used to promote the increase of neutrophils to patients with neutropenia during chemotherapy or donors for hematopoietic stem cell transplantation (HSCT). Its adverse effects were mainly reported as non-serious symptoms, such as back pain, headache, arthralgia and fever. A 29-year-old male was administered the Filgrastim as a HSCT donor. He accompanied left side hearing disturbance and tinnitus after 2 days from
doi:10.35420/jcohns.2018.29.1.87
fatcat:ng6ptpvwcfdfbha55zad4oj4xi